Pulmonary Lymphangitis Carcinomatosis of Clear Cell Renal Cell Carcinoma After Angiogenesis Inhibition

Autor: Kats-Ugurlu, G., Herpen, C.M. van, Mulder, S.F., Prokop, M., Waal, R.M. de, Mulders, P.F.A., Krieken, J.H.J.M. van, Oosterwijk, E., Leenders, W.P.

Publikováno v: Archives of Surgery and Clinical Case Reports, 51

Item does not contain fulltext

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6520dde3560fa85a32f262ff0640c9e
https://hdl.handle.net/2066/215975

Intestinal-type sinonasal adenocarcinomas: The road to molecular diagnosis and personalized treatment

Autor: Hoeben, A., Winkel, L. van de, Hoebers, F., Kross, K., Driessen, C., Slootweg, P.J., Tjan-Heijnen, V.C., Herpen, C.M. van

Publikováno v: Head and Neck-Journal for the Sciences and Specialties of the Head and Neck, 38, 1564-1570. Wiley
Head and Neck : Journal for the Sciences and Specialties of the Head and Neck, 38, 10, pp. 1564-70
Head and Neck : Journal for the Sciences and Specialties of the Head and Neck, 38, 1564-70

Item does not contain fulltext BACKGROUND: Sinonasal intestinal-type adenocarcinomas (ITACs) are epithelial tumors of the nasal cavity and the paranasal sinuses, often related to professional exposure to organic dust, mainly wood or leather. It is a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::84cc6f108cf6f9a7511b472c844c27ee
https://cris.maastrichtuniversity.nl/en/publications/067af396-7f44-4db1-8065-5c222161b42c

mTOR inhibitor-induced interstitial lung disease in cancer patients: Comprehensive review and a practical management algorithm

Autor: Willemsen, A.E., Grutters, J.C., Gerritsen, W.R., Erp, N. van, Herpen, C.M. van, Tol, J.

Publikováno v: International Journal of Cancer, 138, 10, pp. 2312-21
International Journal of Cancer, 138, 2312-21

Item does not contain fulltext Mammalian target of rapamycin inhibitors (mTORi) have clinically significant activity against various malignancies, such as renal cell carcinoma and breast cancer, but their use can be complicated by several toxicities.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0c99d8081d175cc47d8b93921fe3ae2f
https://hdl.handle.net/2066/171991

18-F-FLT-PET for response evaluation of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with solid tumors

Autor: Desar, I.M., Gilles, R., Herpen, C.M. van, Timmer-Bonte, J.N.H., Cantarini, M.V., Graaf, W.T.A. van der, Oyen, W.J.G.

Publikováno v: World Journal of Nuclear Medicine, 2012, 11, pp. 65-67
World Journal of Nuclear Medicine, 2012, 65-67

Contains fulltext : 107703.pdf (Publisher’s version ) (Open Access)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6d64bc3e6ac94a69deb32f19d295646a
https://hdl.handle.net/2066/107703